Novartis' Prexige has been taken off the market and UK doctors instructed to immediately stop prescribing it following several instances …
Novartis will launch Prexige in its first European markets outside the UK next year following its EMEA approval for osteoarthritic …
Global coalition calls for stronger government action on COPD
Global health researchers call for more equitable partnerships
Liverpool launches £20m lab for infectious disease drug discovery
Circle Health Group expands into UK laboratory operations
FibroFind appoints Professor Andrew Fisher as Chief Medical Officer

